Search filters

List of works by Kosh Agarwal

Development and validation of an efficient in-house real-time reverse transcription polymerase chain reaction assay for the quantitative detection of serum hepatitis delta virus RNA in a diverse South London population

scientific article published on May 18, 2012

English hepatitis C registry data show high response rates to directly acting anti-virals, even if treatment is not completed

scientific article published on 22 May 2020

Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection

scientific article published on 19 April 2018

Glecaprevir/Pibrentasvir in Patients with Chronic HCV Genotype 3 Infection: An Integrated Phase 2/3 Analysis

scientific article published on 11 December 2018

HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues.

scientific article

Hepatitis E – an unexpected problem at home

scientific article published on January 10, 2012

Impact Of Direct Acting Antiviral Agents On Liver Function In Patients With Chronic Hepatitis C Virus Infection

scientific article published on 26 September 2020

Increasing burden of liver disease in patients with HIV infection

scientific article published on April 2, 2011

International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS.

scientific article

International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates

scientific article published in May 2017

International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients

Liver transplant listing for hepatitis C associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct acting antiviral therapy

scientific article published on 14 November 2018

Liver transplantation in human immunodeficiency virus-positive patients

scientific article published on August 1, 2011

Massive Gastrointestinal Bleed in a Patient With Primary Sclerosing Cholangitis

scientific article published on March 26, 2011

Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment

scientific article published on 22 August 2018

Serum NGAL can act as an early renal safety biomarker during long-term nucleos(t)ide analogue antiviral therapy in chronic hepatitis B.

scientific article published on 16 April 2018

The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis

scientific article published on 31 May 2019

The impact of inflammatory bowel disease post‐liver transplantation for primary sclerosing cholangitis

scientific article published on November 22, 2011

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients

scientific article published on February 1, 2012